Transgenic mouse models of lymphoma for preclinical analysis of novel anti-cancer drugs.

被引：0
|
作者：
Pedersen, IM
Zapata, JM
Sporn, M
Carson, DA
Leoni, LM
Reed, JC
机构：
[1] Burnham Inst, La Jolla, CA 92037 USA
[2] Dartmouth Coll Sch Med, Hanover, NH USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Salmedix Inc, San Diego, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1365
引用
收藏
页码：352A / 352A
页数：1
相关论文
共 50 条
  • [21] Anti-cancer drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [22] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [23] Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models
    Ernsting, Mark J.
    Tang, Wei-Lun
    MacCallum, Noah W.
    Li, Shyh-Dar
    BIOMATERIALS, 2012, 33 (05) : 1445 - 1454
  • [24] The novel approaches for the development of anti-cancer drugs - Preface
    Bergmann-Leitner, ES
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (16) : U2 - U3
  • [25] Humanized mouse models for evaluation of immunotherapeutic drugs.
    Wulf-Goldenberg, Annika
    Stecklum, Maria
    Brzezicha, Bernadette
    Fichtner, Iduna
    Hoffmann, Jens
    Walther, Wolfgang
    CANCER RESEARCH, 2018, 78 (10) : 37 - 38
  • [26] Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
    Su, Yanwei
    Zhao, Bin
    Zhou, Liangfu
    Zhang, Zheyuan
    Shen, Ying
    Lv, Huanhuan
    AlQudsy, Luban Hamdy Hameed
    Shang, Peng
    CANCER LETTERS, 2020, 483 : 127 - 136
  • [27] Novel approaches to rational design of anti-cancer drugs
    Barlev, Nickolai A.
    Fedorova, Olga
    Daks, Alexandra
    Shuvalov, Oleg
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S68 - S68
  • [28] Novel benzyl substituted titanocene anti-cancer drugs
    Sweeney, NJ
    Mendoza, O
    Müller-Bunz, H
    Pampillón, C
    Rehmann, FJK
    Strohfeldt, K
    Tacke, M
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2005, 690 (21-22) : 4537 - 4544
  • [29] Budgeting novel anti-cancer drugs: with which resources?
    Livartowski, A
    Beuzeboc, P
    Le Vu, B
    Courbard, M
    Pierga, JY
    Extra, JM
    Scholl, S
    Pouillart, P
    BULLETIN DU CANCER, 2000, 87 (10) : 745 - 754
  • [30] Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
    Koga, Yoshikatsu
    Ochiai, Atsushi
    CELLS, 2019, 8 (05)
12345